Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 12Breast Neoplasms 8Vitamin D Deficiency 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 3Leukemia 3Rectal Neoplasms 2Polycystic Ovary Syndrome 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Myelodysplastic-Myeloproliferative Diseases 2Male Urogenital Diseases 2Colorectal Neoplasms 2Colonic Neoplasms 2Warts 1Triple Negative Breast Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain 1Osteoporosis 1Obesity 1Neurofibromatosis 1 1Neuralgia 1Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Lycopene 3padeliporfin 2Vitamin E 2Tea 2Selenium 2Cholecalciferol 2relatlimab 1pembrolizumab 1Therapeutics 1Sugars 1Nivolumab 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Male Urogenital Diseases × Cholecalciferol × Clear all
NCT00744549 2018-02-14

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

University Health Network, Toronto

Phase 2 Completed
16 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

NCT00844792 2017-10-26

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

University Health Network, Toronto

Phase 2 Completed
48 enrolled
Genitourinary

Prostatic Neoplasms, Male Urogenital Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡